Lobbying client

AMARIN PHARM INC.

Pharmaceutical

Filings
14
Filed by
1
Reported in-house
—
Reported by firms
$480,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2019 to 2022

Filings

1 filing for 2022, newest first.
Filing Filed by Amount
1st Quarter - Termination (No Activity)
1st Quarter 2022
BGR GOVERNMENT AFFAIRS — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
BGR GOVERNMENT AFFAIRS 12 $480,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 12

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.